4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000186
Chairperson & CEO sold 9,500 shares at an average $586.32 ($5,570,085)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-10 | Sale : show line 2 in the form 10b5-1 | −40 | $577.52 | $23,101 | 333,903 | I |
| 2026-11-10 | Sale : show line 3 in the form 10b5-1 | −880 | $580.40 | $510,756 | 333,023 | I |
| 2026-11-10 | Sale : show line 4 in the form 10b5-1 | −742 | $581.36 | $431,367 | 332,281 | I |
| 2026-11-10 | Sale : show line 5 in the form 10b5-1 | −618 | $582.42 | $359,937 | 331,663 | I |
| 2026-11-10 | Sale : show line 6 in the form 10b5-1 | −980 | $583.64 | $571,964 | 330,683 | I |
| 2026-11-10 | Sale : show line 7 in the form 10b5-1 | −328 | $584.76 | $191,801 | 330,355 | I |
| 2026-11-10 | Sale : show line 8 in the form 10b5-1 | −795 | $585.56 | $465,517 | 329,560 | I |
| Open-market sales · 9,500 sh · avg $586.32 · $5,570,085 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-10 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option | −9,500 | 52,910 | I |
Loading xslF345X06/primarydocument.xml…